Olympus to Acquire BioProtect for Prostate Cancer Care
TOKYO, Japan, May 26, 2026 Olympus Corporation has announced a definitive agreement to acquire BioProtect Ltd., an Israel-based medical...
Oncology Devices
Advertisement
AngioDynamics NanoKnife Shows Durable Prostate Cancer Control
LATHAM, N.Y., May 13, 2026 AngioDynamics announced new two-year data from the pivotal PRESERVE clinical trial, demonstrating that its...
Sonire Therapeutics Launches U.S. HIFU Trial in Cancer
PALO ALTO, California, May 1, 2026 Sonire Therapeutics Inc. announced the initiation of its first U.S. clinical trial, SUNRISE-II,...
Merit Medical Acquires View Point to Expand Oncology Devices
SOUTH JORDAN, Utah, April 1, 2026 Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc....
Delcath CHEMOSAT Gains ESMO Guideline Recognition Boost
Queensbury, New York, USA, April 6, 2026 ESMO Guideline Inclusion Validates CHEMOSAT Therapy In a major milestone for interventional...
Advertisements
IceCure Reports Strong 5-Year Results in Kidney Cancer
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
Autonomix Reports Rapid, Durable Pain Relief in Pancreatic Cancer
THE WOODLANDS, Texas | January 9, 2026 — Autonomix Medical, Inc. has reported compelling proof-of-concept (PoC) clinical data demonstrating...
IceCure Receives U.S. Patent Allowance for XSense Cryoprobe Technology
September 18, 2025 — Caesarea, Israel IceCure has been granted a Notice of Allowance by the U.S. Patent and...
IceCure Wins Israel Approval for XSense™ Cryoablation System
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
Advertisement
